Edition:
United Kingdom

Karyopharm Therapeutics Inc (KPTI.OQ)

KPTI.OQ on NASDAQ Stock Exchange Global Select Market

11.16USD
16 Nov 2018
Change (% chg)

$0.16 (+1.45%)
Prev Close
$11.00
Open
$10.91
Day's High
$11.18
Day's Low
$10.68
Volume
212,695
Avg. Vol
206,920
52-wk High
$21.69
52-wk Low
$9.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.88 December 17 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 4 4 4
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.70 1.90 1.90 1.90

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 9 0.49 2.46 0.00 0.00
Quarter Ending Mar-19 2 1.65 2.30 1.00 --
Year Ending Dec-18 9 30.58 32.60 29.90 15.96
Year Ending Dec-19 10 33.66 90.60 5.00 58.93
Earnings (per share)
Quarter Ending Dec-18 9 -0.88 -0.53 -1.02 -0.63
Quarter Ending Mar-19 3 -0.94 -0.90 -0.97 --
Year Ending Dec-18 9 -3.14 -2.76 -3.36 -2.25
Year Ending Dec-19 10 -3.25 -2.71 -3.84 -1.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.46 0.24 0.23 48.52
Quarter Ending Jun-18 3.09 19.89 16.81 544.60
Quarter Ending Mar-18 5.84 10.00 4.16 71.32
Quarter Ending Dec-17 0.03 1.53 1.50 4,359.30
Quarter Ending Sep-17 0.03 0.00 0.03 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.49 0.44 0.44 0.44 0.00
Quarter Ending Mar-19 1.65 1.65 1.65 1.70 --
Year Ending Dec-18 30.58 30.81 30.82 30.81 15.96
Year Ending Dec-19 33.66 33.83 33.83 33.44 58.93

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 1 2 4 3
Year Ending Dec-19 0 1 1 1
Earnings